The charges stem from purchases drugs not approved by US Food and Drug Administration from a drug provider in Canada beginning April 2009 through March 2012.Court documents alleged the Sens knowingly bought the misbranded drugs, provided them to their patients and billed Medicare and other government and private health benefits programs for about $3.2 million.